Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Therapeutic results: tacrine]

M Ventura1, J Sternon

  • 1Service de Neurologie, Hôpital Erasme, Bruxelles.

Revue Medicale De Bruxelles
|March 3, 1998
PubMed
Summary

Tacrine is an effective Alzheimer's disease treatment, acting as an acetylcholinesterase inhibitor. This study analyzes its clinical and economic cost-benefit ratio for managing mild to moderate cases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Metagenomic Evaluation of Oral Microbiota in Patients Affected by Oral Lichen Planus: A Pilot Study.

Oral diseases·2026
Same author

Highly conserved bifidobacteria in the human gut: Bifidobacterium longum subsp. longum as a potential modulator of elderly innate immunity.

Beneficial microbes·2024
Same author

Longitudinal changes in bifidobacterial population during the first two years of life.

Beneficial microbes·2024
Same author

Face memory and facial expression recognition are both affected by wearing disposable surgical face masks.

Cognitive processing·2022
Same author

Application of a Fenton process for the pretreatment of an iron-containing oily sludge: A sustainable management for refinery wastes.

Journal of environmental management·2021
Same author

7q35q36.3 deletion and concomitant 20q13.2q13.33 duplication in a newborn: familiar case.

European review for medical and pharmacological sciences·2021

Area of Science:

  • Neuroscience
  • Pharmacology
  • Medical Economics

Context:

  • Alzheimer's disease (AD) is a progressive neurodegenerative disorder.
  • Tacrine was the first centrally acting acetylcholinesterase inhibitor approved for AD.
  • Managing AD involves balancing therapeutic efficacy with economic considerations.

Purpose:

  • To evaluate the cost-benefit ratio of Tacrine for Alzheimer's disease.
  • To assess the clinical effectiveness and economic viability of Tacrine treatment.
  • To provide data for informed decision-making in AD pharmacotherapy.

Summary:

  • Tacrine effectively treats mild to moderate Alzheimer's disease by inhibiting acetylcholinesterase.
  • The drug exhibits cholinomimetic properties, enhancing cholinergic neurotransmission.
  • A comprehensive analysis considered both clinical outcomes and economic data.

Impact:

  • Provides a framework for evaluating the cost-effectiveness of AD medications.
  • Highlights the importance of integrating clinical and economic data in drug assessment.
  • Informs therapeutic strategies for Alzheimer's disease management.

Related Experiment Videos